PuroGen’s pedigree began in 1997 when its founder launched a leading BioMedical company based in Central Florida. The company developed and commercialized patented technologies specializing in the procurement, manufacturing, and sterilization of cadaveric allograft (human) tissue for clinical use.
In 2016 PuroGen expanded its low-temperature VHP sterilization technologies beyond transplants to include medical devices, pharmaceuticals, biotechnology, and agriculture including cannabis, and hemp.
Through a collaborative approach, PuroGen works closely with clients to provide finished commercialized solutions or co-develop solutions tailored to unique challenges involving the delicate sterilization of biofilms to aggressively addressing pathogen control in agriculture including large scale sterilization for air and surfaces required in healthcare, commercial and the ever increasing need in public spaces.
Our non-irradiated solution provides a terminally sterilized allograft (human) tissue while preserving all of the natural biological properties
Does not impact the original properties of cannabis and hemp such as THC, CBD or Terpenes
In-house supply sterilization process with 20 minute cycle times and powerful SAL 10^-6 reduction kill capability
Safely sterilize without affecting the integrity of genetic makeup for biologic material